Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-10 4:57 pm Purchase |
2023-12-31 | 13G | Replimune Group, Inc. REPL |
Baker Bros. Advisors LP | 9,545,336 16.200% |
3,777,109 (+65.48%) |
Filing History |
| 2023-02-14 4:22 pm Purchase |
2022-12-31 | 13G | Replimune Group, Inc. REPL |
Redmile Group LLC | 5,740,099 9.900% |
574,968 (+11.13%) |
Filing History |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | Replimune Group, Inc. REPL |
Baker Bros. Advisors LP | 5,768,227 9.990% |
5,768,227 (New Position) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Replimune Group, Inc. REPL |
PRICE T ROWE ASSOCIATES INC | 5,064,744 9.200% |
-803,894 (-13.70%) |
Filing History |
| 2023-02-13 4:49 pm Sale |
2022-12-31 | 13G | Replimune Group, Inc. REPL |
Omega Fund IV L.P. | 3,610,478 7.200% |
-1,445,074 (-28.58%) |
Filing History |
| 2023-02-03 12:10 pm Purchase |
2022-12-31 | 13G | Replimune Group, Inc. REPL |
BLACKROCK INC BLK |
3,010,552 5.500% |
3,010,552 (New Position) |
Filing History |
| 2022-12-06 5:00 pm Sale |
2022-11-23 | 13D | Replimune Group, Inc. REPL |
Atlas Venture Fund X L.P. | 1,498,635 3.000% |
-665,402 (-30.75%) |
Filing History |
| 2022-11-18 5:17 pm Purchase |
2022-11-14 | 13G | Replimune Group, Inc. REPL |
Redmile Group LLC | 5,165,131 9.900% |
389,670 (+8.16%) |
Filing History |
| 2022-09-14 5:06 pm Sale |
2022-09-12 | 13D | Replimune Group, Inc. REPL |
Atlas Venture Fund X L.P. | 2,164,037 4.400% |
-360,829 (-14.29%) |
Filing History |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Replimune Group, Inc. REPL |
Redmile Group LLC | 4,775,461 9.900% |
117,418 (+2.52%) |
Filing History |
| 2022-02-14 3:18 pm Sale |
2021-12-31 | 13G | Replimune Group, Inc. REPL |
Omega Fund IV L.P. | 5,055,552 10.600% |
-274,231 (-5.15%) |
Filing History |
| 2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Replimune Group, Inc. REPL |
PRICE T ROWE ASSOCIATES INC | 5,868,638 12.500% |
799,188 (+15.76%) |
Filing History |
| 2022-02-09 10:24 am Sale |
2022-02-08 | 13G | Replimune Group, Inc. REPL |
FMR CORP | 1,054,119 2.247% |
-1,572,298 (-59.86%) |
Filing History |
| 2021-07-12 2:57 pm Purchase |
2021-06-30 | 13G | Replimune Group, Inc. REPL |
PRICE T ROWE ASSOCIATES INC | 5,069,450 10.800% |
2,443,759 (+93.07%) |
Filing History |
| 2021-02-16 4:11 pm Purchase |
2020-12-31 | 13G | Replimune Group, Inc. REPL |
Redmile Group LLC | 4,658,043 9.900% |
1,036,408 (+28.62%) |
Filing History |
| 2021-02-16 4:05 pm Sale |
2020-12-31 | 13G | Replimune Group, Inc. REPL |
Coffin Robert | 2,307,300 4.900% |
-234,127 (-9.21%) |
Filing History |
| 2021-02-16 3:15 pm Sale |
2020-12-31 | 13G | Replimune Group, Inc. REPL |
BCLS I Investco, LP | 0 0.000% |
-2,575,360 (Position Closed) |
Filing History |
| 2021-02-16 12:23 pm Purchase |
2020-12-31 | 13G | Replimune Group, Inc. REPL |
PRICE T ROWE ASSOCIATES INC | 2,625,691 5.700% |
2,625,691 (New Position) |
Filing History |
| 2021-02-16 06:36 am Unchanged |
2020-12-31 | 13G | Replimune Group, Inc. REPL |
Forbion Capital Fund III Cooperatief U.A. | 5,115,121 11.130% |
0 (Unchanged) |
Filing History |
| 2021-02-11 5:12 pm Sale |
2020-12-31 | 13G | Replimune Group, Inc. REPL |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-2,309,109 (Position Closed) |
Filing History |